Interventional — Operating Income (Loss)
Becton, Dickinson and Company Interventional — Operating Income (Loss) increased by 522.6% to $579.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.2%, from $383.00M to $579.00M. Over 2 years (FY 2021 to FY 2026), Interventional — Operating Income (Loss) shows a downward trend with a -10.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates improved profitability and operational efficiency, while a decrease signals declining margins or rising costs.
Detailed definition
This metric represents the total operating profit or loss generated by the Interventional segment after accounting for a...
Peer comparison
Standard segment operating income metric used to compare profitability across business units in the medical device industry.
bdx_segment_interventional_operating_income_lossHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $492.00M | $83.00M | $692.00M | $564.00M | $537.00M | $489.00M | $585.00M | $484.75M | $628.00M | $484.75M | $549.00M | $484.75M | $349.00M | $484.75M | $439.00M | $528.75M | $734.00M | $528.75M | $602.00M | $528.75M | $622.00M | $528.75M | $453.00M | $561.00M | $383.00M | $565.00M | $882.00M | $861.00M | $552.00M | $561.00M | $93.00M | $579.00M |
| QoQ Change | — | -83.1% | +733.7% | -18.5% | -4.8% | -8.9% | +19.6% | -17.1% | +29.6% | -22.8% | +13.3% | -11.7% | -28.0% | +38.9% | -9.4% | +20.4% | +38.8% | -28.0% | +13.9% | -12.2% | +17.6% | -15.0% | -14.3% | +23.8% | -31.7% | +47.5% | +56.1% | -2.4% | -35.9% | +1.6% | -83.4% | +522.6% |
| YoY Change | — | — | — | — | +9.1% | +489.2% | -15.5% | -29.9% | +11.3% | -14.1% | +2.2% | -9.7% | -28.6% | -0.9% | -25.0% | -9.6% | +16.9% | -15.8% | +9.7% | -3.7% | +78.2% | +51.5% | +3.2% | +27.8% | -47.8% | -23.0% | +46.5% | +38.4% | +21.9% | +23.8% | -75.7% | +51.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's interventional — operating income (loss)?
- Becton, Dickinson and Company (BDX) reported interventional — operating income (loss) of $579.00M in Q1 2026.
- How has Becton, Dickinson and Company's interventional — operating income (loss) changed year-over-year?
- Becton, Dickinson and Company's interventional — operating income (loss) increased by 51.2% year-over-year, from $383.00M to $579.00M.
- What is the long-term trend for Becton, Dickinson and Company's interventional — operating income (loss)?
- Over 2 years (2021 to 2026), Becton, Dickinson and Company's interventional — operating income (loss) has grown at a -10.9% compound annual growth rate (CAGR), from $2.25B to $1.79B.
- What does interventional — operating income (loss) mean?
- The total operating profit or loss of the Interventional segment.